8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2000 / Intervention study with non-randomized control group
Thirty-nine obese individuals followed a hypocaloric diet for 15 weeks, with blood and subcutaneous adipose tissue analysed before and after treatment for 26 organochlorine compounds, alongside a control group of 57 women. Following treatment (mean body weight loss 9.5 kg), all 19 detected compounds increased in plasma concentration, 15 of which were statistically significant; 5 increased significantly compared to controls. These increases persisted after an 18-week low-fat diet/exercise follow-up, correlated with weight loss (-0.3 >= r >= -0.6, P<0.05), and were also observed in subcutaneous adipose tissue.
Chevrier J, Dewailly E, Ayotte P, et al. Int J Obes Relat Metab Disord, 2000. PMID 11093288
1999 / 6-week, double-blind, randomized, parallel, placebo-controlled trial
In a 6-week randomized trial, 3,181 volunteers aged 2 to 89 freely consumed snack chips containing either olestra or triglycerides (control) at home. At least one gastrointestinal symptom was reported by 38.2% (619/1620) of the olestra group and 36.9% (576/1561) of controls (difference, 1.3 percentage points; P = 0.60). More controls reported nausea (8.4% vs 5.7%; P = 0.02), while the olestra group reported 1 more symptom-day of more frequent bowel movements (3.7 vs 2.8 days; P = 0.04). The groups did not differ in the impact of symptoms on daily activities.
Sandler RS, Zorich NL, Filloon TG, et al. Ann Intern Med, 1999. PMID 10068382
1999 / Randomized controlled trial
A randomized trial assigned 75 adult male smokers to receive daily placebo, 200 mg, or 1000 mg of ascorbic acid for four weeks. Blood lead levels dropped by 81% after one week in the 1000 mg group (p <= 0.001). Neither the placebo nor the 200 mg daily dose produced any changes in blood or urine lead levels.
Dawson EB, Evans DR, Harris WA, et al. J Am Coll Nutr, 1999. PMID 10204833
1999 / Double-blind, placebo-controlled oral food challenge study
Researchers evaluated the allergenicity of goat's milk (GM) in 26 children with proven IgE-mediated cow's milk allergy (CMA) using skin tests, specific IgE detection, and double-blind, placebo-controlled oral food challenges (DBPCOFCs). All 26 children showed positive skin test responses and CAP results to both cow's milk (CM) and GM, and all reacted positively in DBPCOFCs to CM. Furthermore, 24 of 26 children had positive DBPCOFC results to GM. Inhibition assays showed cross-reactivity between CM and GM, leading authors to conclude that GM is not an appropriate substitute for children with IgE-mediated CMA.
Bellioni-Businco B, Paganelli R, Lucenti P, et al. J Allergy Clin Immunol, 1999. PMID 10359905
1999 / Intervention study
Twenty-five healthy female volunteers consumed a fish meal with nitrate-containing drinking water for 7 days, alongside tests assessing ascorbic acid (250 mg and 1 g/day) and green tea (2 g and 4 g/day). Fish and nitrate intake significantly increased urinary NDMA excretion compared with control weeks (871+/-430 and 640+/-277 ng/24 h during days 1-3 and 4-7 vs. 385+/-196 ng/24 h; p<0.0002). Both 250 mg and 1 g/day ascorbic acid significantly decreased NDMA excretion during days 4-7 (p=0.0001), as did 2 g/day green tea (p=0.0035). Conversely, 4 g/day green tea significantly increased NDMA excretion during days 4-7 (p=0.0001), while NPIP excretion remained unrelated to intake.
Vermeer IT, Moonen EJ, Dallinga JW, et al. Mutat Res, 1999. PMID 10518007
1999 / Case report / intervention
Two patients with chloracne had 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) levels of 144,000 and 26,000 pg/g blood lipids. Ingestion of olestra, a non-digestible lipophilic dietary fat substitute, accelerated intestinal excretion of TCDD by eight- to tenfold. This rate of increase is sufficient to decrease the normally observed TCDD elimination half-life from approximately 7 years to 1-2 years.
Geusau A, Tschachler E, Meixner M, et al. Lancet, 1999. PMID 10520643
1998 / Intervention study with pre- and post-control periods
Twenty-five volunteers consumed an amine-rich fish meal along with nitrate at the acceptable daily intake (ADI) level for 7 consecutive days, preceded and followed by 1-week control periods on a low-nitrate diet. Mean urinary nitrate excretion rose from 76 mg/24 hr in the first control week to 194 and 165 mg/24 hr in the test week, then fell to 77 mg/24 hr in the second control week. Mean urinary N-nitrosodimethylamine (NDMA) excretion increased from 287 ng/24 hr in the control week to 871 and 640 ng/24 hr in the test week, and declined to 383 ng/24 hr in the second control week. Urinary excretion of N-nitrosopiperidine was not directly related to nitrate intake, but NDMA excretion correlated significantly with nitrate excretion and salivary nitrate and nitrite concentrations.
Vermeer IT, Pachen DM, Dallinga JW, et al. Environ Health Perspect, 1998. PMID 9681972
1997 / Double-blind randomized crossover oral challenge study
In 61 self-identified MSG-sensitive subjects, oral challenges were conducted with MSG or placebo, followed by rechallenge with varying doses (placebo, 1.25, 2.5, and 5 gm MSG) in those reacting to a single agent. On initial challenge, 29.5% responded to neither, 9.8% to both, 24.6% to placebo, and 36.1% to MSG (p = 0.324). Total and average symptom severity scores were higher after MSG (374 and 80) than placebo (232 and 56; p = 0.026 and 0.018). Headache, muscle tightness, numbness/tingling, general weakness, and flushing were significantly more frequent after MSG, with an apparent threshold dose of 2.5 gm MSG.
Yang WH, Drouin MA, Herbert M, et al. J Allergy Clin Immunol, 1997. PMID 9215242
1997 / Intervention study
A microwave-assisted acid digestion procedure coupled with graphite furnace atomic absorption was used to determine aluminum in the urine of four volunteers after drinking tea. Significant urinary aluminum excretion was observed in 24-h urine following tea consumption. However, the difference in urinary aluminum excretion between consuming Oolong tea and Long-Jin green tea was not significant, suggesting high levels of free aluminum species in infusions did not lead to significant excretion differences. The authors noted that potential differences in body retention or excretion via bile or feces could not be excluded.
Wu J, Zhou CY, Wong MK, et al. Biol Trace Elem Res, 1997. PMID 9359993
1994 / Experimental animal study and human comparative testing
Mice were injected with commercially purified or HPLC-repurified ovalbumin, showing antibody responses to commercial ovalbumin were largely directed against minor (< 1%) ovomucoid contamination. In 18 children with egg allergy, skin prick wheal diameters were significantly greater for DEAE-repurified ovomucoid than ovalbumin, lysozyme, and egg white extract at concentrations of 0.01, 0.03, and 0.1 mg/ml (p < 0.01). Serum ovomucoid-specific IgE and IgG levels were also significantly greater than those to ovalbumin (p < 0.05). Furthermore, in 10 patients with persistent hypersensitivity versus 11 who developed tolerance, IgE to repurified ovomucoid was significantly higher at initial and follow-up challenges, with no differences observed for ovalbumin IgE.
Bernhisel-Broadbent J, Dintzis HM, Dintzis RZ, et al. J Allergy Clin Immunol, 1994. PMID 8006309
1993 / Three-way crossover study
Twelve healthy volunteers on a controlled aluminium (Al) diet consumed a tea infusion (500 ml/70 kg body weight) with milk, with lemon juice, or mineral water across a three-way crossover design. Plasma Al concentrations were measured before and up to 24 hours after consumption. Intake of up to 1.60 mg Al from tea with milk or lemon juice did not raise plasma Al levels compared with drinking mineral water containing approximately 0.001 mg Al.
Drewitt PN, Butterworth KR, Springall CD, et al. Food Chem Toxicol, 1993. PMID 8444383
1993 / Double-blind, four-way crossover trial
In a double-blind, four-way crossover study, 32 healthy volunteers consumed lactose placebo, or 80, 120, or 160 mg quinine HCl daily for 21 days. Doses up to 80 mg daily did not significantly alter physiological, ophthalmic, or audiometric parameters. Electronystagmography showed that ocular motor oscillations occurred in 12.5% of volunteers on placebo or 80 mg, and in 18.8% (P < 0.05) on 120 mg or more, but without a significant dose-related correlation. One volunteer experienced altered red/green color vision after 160 mg/day for 21 days, establishing a no-untoward-effect level of at least 80 mg/day.
Drewitt PN, Butterworth KR, Springall CD, et al. Food Chem Toxicol, 1993. PMID 8477913
1993 / Intervention trial with in vitro microsomal component
Researchers evaluated the effects of grapefruit juice and naringenin on human CYP1A2 activity using caffeine as a probe substrate. In vitro, naringin competitively inhibited caffeine 3-demethylation by human liver microsomes (Ki = 7-29 microM). In vivo among 12 participants, grapefruit juice (1.2 l day-1 containing 0.5 g l-1 naringin) decreased oral caffeine clearance by 23% (95% CI: 7%-30%) and prolonged its half-life by 31% (95% CI: 20%-44%). The authors concluded that while grapefruit juice inhibits CYP1A2, the small in vivo effect suggests it generally should not cause clinically significant inhibition of other CYP1A2 drug substrates.
Fuhr U, Klittich K, Staib AH Br J Clin Pharmacol, 1993. PMID 8485024
1992 / Interventional study (before-and-after diet change)
Faecal elimination of lead and cadmium was evaluated in 16 subjects who transitioned from a mixed diet to a lactovegetarian diet. Faecal weight increased significantly after the change to the vegetarian diet, partly due to increased water content. Large inter-individual variation was seen for lead (mixed: range 14-118, median 31 micrograms Pb/day; vegetarian: range 19-136, median 42 micrograms Pb/day) and cadmium (mixed: range 4.5-21, median 12 micrograms Cd/day; vegetarian: range 6.1-24, median 14 micrograms Cd/day). Although there was a tendency toward increased faecal elimination of both metals on the vegetarian diet, the differences were not statistically significant.
Vahter M, Johansson G, Akesson A, et al. Food Chem Toxicol, 1992. PMID 1628863
1991 / Interventional feeding study
Faecal concentrations of apparent total N-nitroso compounds (ATNC) were measured in humans consuming a normal diet, followed by an 8-day diet low in nitrate and ATNC, and then nitrate supplementation (300 mg/day). On normal diets, concentrations ranged from 40 to 590 micrograms (N-NO)/kg faeces, which decreased to below the 40 micrograms/kg limit up to 143 micrograms/kg (mean 82 micrograms/kg) on the low-nitrate diet. Supplementing with 300 mg nitrate/day increased faecal ATNC levels to a range of 73-714 micrograms/kg (mean 307 micrograms/kg) by the third day, indicating endogenous formation from dietary nitrate is likely an important source.
Rowland IR, Granli T, Bøckman OC, et al. Carcinogenesis, 1991. PMID 1860160
1987 / Randomized placebo-controlled trial
Fifty-two adult male subjects were randomly assigned to receive supplemental ascorbic acid at 500 mg, 1000 mg, or a placebo for three months. Hair and blood samples were collected at baseline and at monthly intervals to measure cadmium, lead, and mercury. Results showed that vitamin C supplementation did not significantly affect levels of these metals in either hair or blood samples.
Calabrese EJ, Stoddard A, Leonard DA, et al. Ann N Y Acad Sci, 1987. PMID 3476002
1986 / Randomized controlled trial
Ten subjects with normal renal function took single doses of aluminium-containing antacids (1, 4, or 8 tablets containing 244 mg aluminium per tablet) with water, orange juice, or citric acid solution. Serum aluminium increased markedly when antacids were taken with citric acid (P < 0.001) or orange juice (P < 0.05), whereas taking them with water produced only a slight increase with 4 tablets. A significant increase in 24-hour urinary aluminium excretion followed all antacid doses. Estimated aluminium absorption was 8 and 50 times higher when antacids were taken with orange juice or citric acid, respectively, compared to water.
Weberg R, Berstad A Eur J Clin Invest, 1986. PMID 3100311
1986 / Experimental intervention trial
Ten healthy men ingested citric acid (as lemon juice), Al(OH)3, or Al(OH)3 plus citric acid twice daily between meals during 7-day periods. Mean whole blood aluminum concentrations increased from a pretreatment level of 5 (SD 3) micrograms/L to 9 (SD 4) micrograms/L after citric acid and 12 (SD 3) micrograms/L after Al(OH)3. Combined ingestion of Al(OH)3 and citric acid caused a more pronounced, highly significant increase to 23 (SD 2) micrograms Al/L (p < 0.001).
Slanina P, Frech W, Ekström LG, et al. Clin Chem, 1986. PMID 3948402
1985 / Interventional trials
Urine morphine levels after consuming poppy seeds were measured across two separate trials. Maximum urine morphine levels reached approximately 18 micrograms/ml using RIA, EMIT-ST, and GC methodologies, and positive immunoassay results persisted for up to 60 hours post-ingestion. Assayed poppy seed lots contained morphine ranging from 4 to 200 mg/kg. Identifying minor alkaloid constituents did not differentiate poppy seed eaters from opiate users, though opiate urines could be analyzed for 6-O-acetylmorphine.
Fritschi G, Prescott WR Forensic Sci Int, 1985. PMID 3979930
1985 / Interventional uptake study
Twenty-three adults ingested 203Pb as lead acetate at the 12th hour of a 19-hour fast or alongside various foods and substances. Retention measured 7 days later in a whole-body counter was 61% after fasting, whereas balanced meals eaten with 203Pb reduced lead uptake to 4%, with the effect of food lasting up to 3 hours. Phytate, EDTA, caffeine, alcohol, glucose, a liquid meal, and a light snack yielded intermediate uptake results.
James HM, Hilburn ME, Blair JA Hum Toxicol, 1985. PMID 4018820
1984 / Intervention study with observational comparisons
Volunteers ingested known amounts of various food products to assess their effect on 24-hour urinary nitrosoproline (NPRO) excretion. Consuming nitrite-preserved meats (85-170 g per meal) led to urinary NPRO levels of 2.5 to 78.5 micrograms/24 h, compared to 0.0 to 0.8 micrograms/24 h for non-preserved meat and fish, and averages of 0.8 and 1.4 micrograms/24 h in 22 vegetarians and 14 lacto-vegetarians. Switching from a nitrite-preserved meat diet to a vegetarian diet reduced urinary NPRO levels approximately six-fold, though levels stayed above control for at least 3 days. Nitrite-trapping chemicals (such as ascorbic acid, ferulic acid, caffeic acid, coffee, or tea) did not reduce NPRO excretion after preserved meat ingestion, suggesting the presence of preformed NPRO.
Stich HF, Hornby AP, Dunn BP Int J Cancer, 1984. PMID 6724737
1983 / Human challenge study and animal transmission experiment
A human volunteer immune to hepatitis A virus was orally administered pooled stool extracts from presumed cases of epidemic non-A, non-B hepatitis. Typical acute hepatitis was reproduced without detectable hepatitis B markers, anti-HAV IgM, or increases in total anti-HAV. Spherical 27- to 30-nm virus-like particles (buoyant density 1.35 g/cm3 in CsCl) were detected in stool samples and reacted with sera from individuals with prior non-B hepatitis episodes. Intravenous inoculation of cynomolgus monkeys also resulted in histopathologically and enzymatically confirmed hepatitis with particle excretion.
Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Intervirology, 1983. PMID 6409836
1983 / Single-blind controlled trial
A single-blind study assessed whether daily oral supplementation with vitamin C (1 g orally once daily, 5 times a week for 20 weeks; n=39) or zinc (60 mg zinc as zinc gluconate once daily, 5 times a week for 8 weeks; n=11) influenced lead absorption and biological response compared to matched placebo controls. Baseline blood lead levels ranged from 28.9 to 76.4 micrograms/100 ml. In workers with moderate inorganic lead exposure and no nutritional deficiencies, oral supplementation of vitamin C or zinc did not influence the metabolism and biological action of lead.
Lauwerys R, Roels H, Buchet JP, et al. J Occup Med, 1983. PMID 6631566
1983 / Interventional trial in humans and animals
Healthy human subjects were administered 27 millimoles of choline chloride, choline stearate, or lecithin. These treatments markedly increased urinary excretion of TMA, DMA, and MMA, with choline chloride showing the greatest effect. Rats treated with 2 mmol/kg b.wt. of choline chloride or lecithin showed significantly increased urinary TMA excretion without alterations in DMA or MMA excretion. Commercially available lecithins and choline stearate were found to be contaminated with methylamines, and prior removal of methylamines from lecithin minimized its effect on urinary methylamine excretion in both rats and humans.
Zeisel SH, Wishnok JS, Blusztajn JK J Pharmacol Exp Ther, 1983. PMID 6842395